Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group

Item Type:	Letter
Title:	Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group
Creators Name:	Theis, F. and Corbacioglu, A. and Gaidzik, V.I. and Paschka, P. and Weber, D. and Bullinger, L. and Heuser, M. and Ganser, A. and Thol, F. and Schlegelberger, B. and Göhring, G. and Köhne, C.H. and Germing, U. and Brossart, P. and Horst, H.A. and Haase, D. and Götze, K. and Ringhoffer, M. and Fiedler, W. and Nachbaur, D. and Kindler, T. and Held, G. and Lübbert, M. and Wattad, M. and Salih, H.R. and Krauter, J. and Döhner, H. and Schlenk, R.F. and Döhner, K.
Keywords:	Acute Myeloid Leukemia, CCAAT-Enhancer-Binding Proteins, Cohort Studies, GATA2 Transcription Factor, Mutation, Young Adult
Source:	Leukemia
ISSN:	0887-6924
Publisher:	Nature Publishing Group
Volume:	30
Number:	11
Page Range:	2248-2250
Date:	November 2016
Official Publication:	https://doi.org/10.1038/leu.2016.185
PubMed:	View item in PubMed

Repository Staff Only: item control page